Skip to main content

Table 5 Median, minimum (Min) and maximum (Max) values of serum sphingomyelin (SM) species in patients with PCSK9 levels below and above the median level. * P < 0.05

From: Proprotein convertase subtilisin/kexin type 9 (PCSK9) levels are not associated with severity of liver disease and are inversely related to cholesterol in a cohort of thirty eight patients with liver cirrhosis

SM species (μmol/L)

SVP PCSK9 below the median level

(16 patients)

SVP PCSK9 above the median level

(15 patients)

P-value

 

Median

Min

Max

Median

Min

Max

 

SM 14:0

4.9

2.7

9.0

4.4

2.0

5.8

 

SM 15:0

2.9

1.5

4.7

2.3

0.9

3.9

 

SM16:1

11.2

5.7

22.3

8.0

4.7

16.6

 

SM16:0

69.2

40.3

126.6

58.6

26.3

86.3

 

SM 18:2

0.2

0.0

0.9

0.3

0.0

0.6

 

SM 18:1

5.8

2.4

12.2

3.6

1.8

9.2

 

SM 18:0

9.8

3.8

18.7

6.2

0.0

12.4

*

SM 20:1

3.0

1.4

5.3

2.3

1.4

3.6

*

SM 20:0

6.1

2.2

9.8

6.9

2.6

11.3

 

SM 22:2

2.1

0.0

3.9

2.1

0.0

4.5

 

SM 22:1

12.8

6.8

21.4

10.3

0.0

18.6

 

SM 22:0

11.2

5.2

20.3

9.2

4.9

16.1

 

SM 23:1

5.9

2.5

12.3

4.5

2.8

9.0

 

SM 23:0

3.7

1.1

8.8

2.9

1.7

6.2

 

SM 24:3

1.6

0.0

3.6

1.5

0.3

4.3

 

SM 24:2

20.9

10.8

36.6

15.9

10.7

24.2

*

SM 24:1

50.1

36.1

95.0

41.8

18.4

71.2

*

SM 24:0

7.1

4.7

13.6

6.6

3.3

10.9

 

SM 26:2

0.5

0.0

1.0

0.3

0.0

1.1

 

SM 26:1

0.5

0.0

1.1

0.3

0.0

0.8

Â